Search Results - "Wertheim, M S"

Refine Results
  1. 1

    Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease by Myers, T D, Smith, J R, Wertheim, M S, Egan, R A, Shults, W T, Rosenbaum, J T

    Published in British journal of ophthalmology (01-05-2004)
    “…Aim: To describe the authors’ experience and that in the published literature regarding the use of corticosteroid sparing systemic immunosuppression for…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Corneal transplant rejection following influenza vaccination by Wertheim, M S, Keel, M, Cook, S D, Tole, D M

    Published in British journal of ophthalmology (01-07-2006)
    “…Immune privilege is due, in part, to the fact that the cornea is devoid of blood and lymph vessels in the host bed and the lack of MHC class II antigen…”
    Get full text
    Journal Article
  4. 4

    Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin by Kris, M G, Gralla, R J, Clark, R A, Tyson, L B, O'Connell, J P, Wertheim, M S, Kelsen, D P

    Published in Journal of clinical oncology (01-10-1985)
    “…Although many trials have evaluated the severity and treatment of nausea and vomiting immediately after cisplatin administration, no studies have focused on…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy by Wertheim, M S, Hakes, T B, Daghestani, A N, Nori, D, Smith, D H, Lewis, Jr, J L

    Published in Journal of clinical oncology (01-07-1985)
    “…The prognosis after surgical therapy (radical hysterectomy and pelvic lymphadenectomy) of stages IB and IIA carcinoma of the cervix is affected by several…”
    Get more information
    Journal Article
  12. 12

    Dapsone induced haemolytic anaemia in patients treated for ocular cicatricial pemphigoid by Wertheim, M S, Males, J J, Cook, S D, Tole, D M

    Published in British journal of ophthalmology (01-04-2006)
    “…Definitive diagnosis is made by immunofluorescent staining of conjunctival tissue demonstrating IgG, IgM, and or IgA in the basement membrane. 1 Dapsone is an…”
    Get full text
    Journal Article
  13. 13

    Third virial coefficient of hard spheroids by WERTHEIM, M. S.

    Published in Molecular physics (10-02-2001)
    “…The third virial coefficient B 3 of a fluid of spheroids is calculated by direct integration using the method of 2-point measures of convex body geometry…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Phase I trial of taxol given as a 3-hour infusion every 21 days by Kris, M G, O'Connell, J P, Gralla, R J, Wertheim, M S, Parente, R M, Schiff, P B, Young, C W

    Published in Cancer treatment reports (01-05-1986)
    “…Taxol is a unique plant product that promotes in vitro assembly of microtubules. In a phase I trial, adults with advanced solid tumors were given taxol…”
    Get more information
    Journal Article
  17. 17

    Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer by Kris, M G, Gralla, R J, Wertheim, M S, Kelsen, D P, O'Connell, J P, Burke, M T, Fiore, J J, Cibas, I R, Heelan, R T

    Published in Cancer treatment reports (01-09-1986)
    “…In prior trials, mitomycin, vindesine, and cisplatin have each been shown to have reproducible antitumor activity as single agents when used in the treatment…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer by KRIS, M. G, KINAHAN, J. J, SIROTNAK, F. M, GRALLA, R. J, FANUCCHI, M. P, WERTHEIM, M. S, O'CONNELL, J. P, MARKS, L. D, WILLIAMS, L, FARAG, F, YOUNG, C. W

    Published in Cancer research (Chicago, Ill.) (01-10-1988)
    “…10-Ethyl-10-deazaaminopterin (10-EDAM) is an analogue of methotrexate with improved preclinical anticancer activity, more selective entry, and greater…”
    Get full text
    Journal Article